Accounts Receivable, after Allowance for Credit Loss, Current in USD of CorMedix Inc. from Q4 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
CorMedix Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2012 to Q3 2025.
  • CorMedix Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 30 Sep 2025 was $159M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

CorMedix Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $159M* +$141M 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $42.9M +$42.7M +20697% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $54.6M 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $51.7M 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $17.4M 30 Sep 2024 10-Q 30 Oct 2024
Q2 2024 $206K 30 Jun 2024 10-Q 14 Aug 2024
Q4 2018 $10.9K -$53.2K -83% 31 Dec 2018 10-K 29 May 2019
Q4 2017 $64.1K +$52.1K +434% 31 Dec 2017 10-K 29 May 2019
Q4 2016 $12K -$304K -96.2% 31 Dec 2016 10-K 19 Mar 2018
Q4 2015 $316K +$236K +294% 31 Dec 2015 10-K 16 Mar 2017
Q4 2014 $80.2K +$77.8K +3328% 31 Dec 2014 10-K 15 Mar 2016
Q4 2013 $2.34K +$2.34K 31 Dec 2013 10-K 12 Mar 2015
Q4 2012 $0 31 Dec 2012 10-K 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.